News

Solvay Healthcare Limited, Pfizer Limited and Procter & Gamble Pharmaceuticals UK, Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry.
To highlight these breaches, all are the subjects of advertisements in the medical, pharmaceutical and nursing press. In addition Solvay has been publicly reprimanded.

The Prescription Medicines Code of Practice Authority (PMCPA) has now published its public consultation on proposed amendments to the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry.

Astellas Pharma named in advertisements following breaches of the ABPI Code of Practice.

ProStrakan Group plc, Cephalon UK Limited and GlaxoSmithKline Consumer Healthcare have each breached the ABPI Code of Practice for the Pharmaceutical Industry.
​To highlight these breaches, all are the subject of advertisements in the medical, pharmaceutical and nursing press.

Novo Nordisk Limited, Eli Lilly and Company Limited, Grünenthal Ltd and Napp Pharmaceuticals Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry. 

Allergan Limited and Cephalon (UK) Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry. To highlight these breaches, both are the subject of advertisements in the medical, pharmaceutical and nursing press.

Chiesi Limited, Eli Lilly and Company Limited and Bayer Healthcare have each breached Clause 2 of the ABPI Code of Practice. Bayer Schering Pharma has been publicly reprimanded.

Bayer Healthcare has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.

Bayer Healthcare has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.

Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry have been sent to companies and published on the PMCPA website.